Home › Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags
 

Keywords :   


Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags

2016-01-25 23:04:06| Biotech - Topix.net

On average, analysts reporting to Thomson Reuters are looking for JNJ earnings of $1.42 a share on top-line sales of $17.9 billion. Short-term option traders are looking for the earnings news to potentially generate a 2.5% move on the stock in either direction.

Tags: product deal johnson earnings

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »